MPPE1
gene geneOn this page
Also known as PGAP5Cdc1
Summary
MPPE1 (metallophosphoesterase 1, HGNC:15988) is a protein-coding gene on chromosome 18p11.21, encoding Metallophosphoesterase 1 (Q53F39). Metallophosphoesterase that catalyzes the removal of a side-chain ethanolamine-phosphate (EtNP) from the second mannose of the GPI-anchor protein intermediate.
Predicted to enable GPI anchor binding activity; GPI-mannose ethanolamine phosphate phosphodiesterase activity; and manganese ion binding activity. Involved in GPI anchor biosynthetic process. Located in Golgi apparatus and nucleoplasm.
Source: NCBI Gene 65258 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 67 total — 2 pathogenic
- MANE Select transcript:
NM_023075
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15988 |
| Approved symbol | MPPE1 |
| Name | metallophosphoesterase 1 |
| Location | 18p11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PGAP5, Cdc1 |
| Ensembl gene | ENSG00000154889 |
| Ensembl biotype | protein_coding |
| OMIM | 611900 |
| Entrez | 65258 |
Gene structure
Transcript identifiers
Ensembl transcripts: 69 — 53 protein_coding, 7 protein_coding_CDS_not_defined, 5 retained_intron, 3 nonsense_mediated_decay, 1 non_stop_decay
ENST00000309976, ENST00000317235, ENST00000317251, ENST00000344987, ENST00000496196, ENST00000586204, ENST00000586364, ENST00000586844, ENST00000587381, ENST00000587724, ENST00000588072, ENST00000588103, ENST00000588186, ENST00000588191, ENST00000588939, ENST00000589267, ENST00000589731, ENST00000589829, ENST00000589859, ENST00000590302, ENST00000590501, ENST00000591667, ENST00000592180, ENST00000592306, ENST00000592331, ENST00000592447, ENST00000592755, ENST00000592894, ENST00000592977, ENST00000593001, ENST00000882028, ENST00000882029, ENST00000882030, ENST00000882031, ENST00000882032, ENST00000882033, ENST00000882034, ENST00000882035, ENST00000882036, ENST00000882037, ENST00000882038, ENST00000882039, ENST00000882040, ENST00000882041, ENST00000882042, ENST00000882043, ENST00000882044, ENST00000913098, ENST00000913099, ENST00000957382, ENST00000957383, ENST00000957384, ENST00000957385, ENST00000957386, ENST00000957387, ENST00000957388, ENST00000957389, ENST00000957390, ENST00000957391, ENST00000957392, ENST00000957393, ENST00000957394, ENST00000957395, ENST00000957396, ENST00000957397, ENST00000957398, ENST00000957399, ENST00000957400, ENST00000957401
RefSeq mRNA: 4 — MANE Select: NM_023075
NM_001242904, NM_001319154, NM_001330563, NM_023075
CCDS: CCDS11853, CCDS56054, CCDS82242
Canonical transcript exons
ENST00000588072 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001276269 | 11886499 | 11886621 |
| ENSE00001276276 | 11886713 | 11886778 |
| ENSE00001276292 | 11906203 | 11906309 |
| ENSE00001851987 | 11908201 | 11908317 |
| ENSE00002942614 | 11882622 | 11884627 |
| ENSE00003505243 | 11888669 | 11888743 |
| ENSE00003555849 | 11886917 | 11887025 |
| ENSE00003663206 | 11893468 | 11893576 |
| ENSE00003667620 | 11885676 | 11885816 |
| ENSE00003668259 | 11896984 | 11897356 |
| ENSE00003789129 | 11889387 | 11889490 |
Expression profiles
Bgee: expression breadth ubiquitous, 285 present calls, max score 96.23.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.8085 / max 123.7697, expressed in 1801 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 171224 | 7.0132 | 1757 |
| 171225 | 4.7953 | 1685 |
Top tissues by expression
296 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 96.23 | gold quality |
| blood | UBERON:0000178 | 95.35 | gold quality |
| monocyte | CL:0000576 | 94.94 | gold quality |
| leukocyte | CL:0000738 | 94.94 | gold quality |
| mononuclear cell | CL:0000842 | 94.92 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.49 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 94.43 | gold quality |
| thyroid gland | UBERON:0002046 | 94.23 | gold quality |
| skin of leg | UBERON:0001511 | 94.08 | gold quality |
| right lung | UBERON:0002167 | 94.04 | gold quality |
| metanephros cortex | UBERON:0010533 | 93.80 | gold quality |
| apex of heart | UBERON:0002098 | 93.79 | gold quality |
| skin of abdomen | UBERON:0001416 | 93.78 | gold quality |
| body of pancreas | UBERON:0001150 | 93.65 | gold quality |
| stromal cell of endometrium | CL:0002255 | 93.45 | gold quality |
| calcaneal tendon | UBERON:0003701 | 93.36 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.35 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 93.19 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 93.16 | gold quality |
| gall bladder | UBERON:0002110 | 93.07 | gold quality |
| rectum | UBERON:0001052 | 92.93 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 92.89 | gold quality |
| upper lobe of lung | UBERON:0008948 | 92.80 | gold quality |
| adenohypophysis | UBERON:0002196 | 92.68 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 92.54 | gold quality |
| spleen | UBERON:0002106 | 92.47 | gold quality |
| nucleus accumbens | UBERON:0001882 | 92.45 | gold quality |
| zone of skin | UBERON:0000014 | 92.41 | gold quality |
| body of stomach | UBERON:0001161 | 92.33 | gold quality |
| thoracic aorta | UBERON:0001515 | 92.24 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.42 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting MPPE1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-6848-3P | 99.64 | 66.49 | 885 |
| HSA-MIR-3682-3P | 99.58 | 67.63 | 865 |
| HSA-MIR-4276 | 99.56 | 67.66 | 2514 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
| HSA-MIR-5683 | 99.36 | 68.59 | 2083 |
| HSA-MIR-6843-3P | 99.26 | 66.42 | 915 |
| HSA-MIR-1207-3P | 98.99 | 66.22 | 1532 |
| HSA-MIR-3145-3P | 98.85 | 69.07 | 2031 |
| HSA-MIR-589-5P | 98.72 | 66.96 | 927 |
| HSA-MIR-6782-3P | 97.60 | 67.75 | 931 |
| HSA-MIR-6748-3P | 97.20 | 65.66 | 836 |
| HSA-MIR-3126-3P | 97.17 | 66.51 | 468 |
| HSA-MIR-4536-3P | 97.06 | 66.88 | 175 |
| HSA-MIR-4690-3P | 97.02 | 64.72 | 981 |
| HSA-MIR-5685 | 97.02 | 64.34 | 1004 |
| HSA-MIR-7846-3P | 96.92 | 65.18 | 51 |
| HSA-MIR-4436B-5P | 96.71 | 68.37 | 1346 |
| HSA-MIR-3976 | 96.67 | 67.79 | 1187 |
| HSA-MIR-6856-3P | 96.47 | 66.27 | 781 |
| HSA-MIR-635 | 96.00 | 65.54 | 687 |
| HSA-MIR-6774-5P | 95.94 | 65.18 | 722 |
Literature-anchored findings (GeneRIF, showing 4)
- cDNA cloning, genomic organization and expression of the novel human metallophosphoesterase gene MPPE1 on chromosome 18p11.2 (PMID:11978971)
- Data demonstrate that glycosylphosphatidylinositol(GPI) glycan acts as an endoplasmic reticulum-exit signal and suggest that glycan remodeling mediated by PGAP5 regulates GPI-anchored proteins transport in the early secretory pathway. (PMID:19837036)
- These results provide evidence of an association between a polymorphism in the MPPE1 gene and bipolar disorder. (PMID:19859903)
- Metallophosphoesterase 1, a novel candidate gene in hepatocellular carcinoma malignancy and recurrence. (PMID:33054568)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mppe1 | ENSDARG00000045416 |
| mus_musculus | Mppe1 | ENSMUSG00000062526 |
| rattus_norvegicus | Mppe1 | ENSRNOG00000018648 |
| drosophila_melanogaster | PGAP5 | FBGN0031997 |
| caenorhabditis_elegans | mppe-1 | WBGENE00015238 |
Protein
Protein identifiers
Metallophosphoesterase 1 — Q53F39 (reviewed: Q53F39)
Alternative names: Post-GPI attachment to proteins factor 5
All UniProt accessions (15): Q53F39, A0A075B777, A0A0A0MR93, A0A0C4DH11, K7EIQ0, K7EJU0, K7ELZ7, K7EM03, K7EQ70, K7EQ74, K7EQV4, K7ER13, K7ERI3, K7ES91, K7ESB8
UniProt curated annotations — full annotation on UniProt →
Function. Metallophosphoesterase that catalyzes the removal of a side-chain ethanolamine-phosphate (EtNP) from the second mannose of the GPI-anchor protein intermediate. Participates in the glycan remodeling steps of GPI-anchor maturation to allow an efficient transport of GPI-anchor proteins from the endoplasmic reticulum to the Golgi.
Subunit / interactions. Interacts with GPI-anchor proteins (via the GPI portion). Interacts with TMED10.
Subcellular location. Endoplasmic reticulum-Golgi intermediate compartment membrane.
Tissue specificity. Expressed in brain.
Cofactor. Binds 2 manganese ions per subunit.
Domain organisation. The di-lysine motif (KxKxx) acts as an endoplasmic reticulum retrieval signal.
Similarity. Belongs to the metallophosphoesterase superfamily. MPPE1 family.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q53F39-1 | 1 | yes |
| Q53F39-2 | 2 | |
| Q53F39-3 | 3 | |
| Q53F39-4 | 4 | |
| Q53F39-5 | 5 |
RefSeq proteins (4): NP_001229833, NP_001306083, NP_001317492, NP_075563* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004843 | Calcineurin-like_PHP | Domain |
| IPR029052 | Metallo-depent_PP-like | Homologous_superfamily |
| IPR033308 | PGAP5/Cdc1/Ted1 | Family |
| IPR039541 | MPP_MPPE1 | Domain |
Pfam: PF00149
Catalyzed reactions (Rhea), 1 shown:
- [protein]-C-terminal carboxyl phosphoethanolamide-GPI(deacylinositol-H8) + H2O = [protein]-C-terminal carboxyl phosphoethanolamide-GPI(deacylinositol-H7) + phosphoethanolamine + H(+) (RHEA:83747)
UniProt features (35 total): mutagenesis site 9, binding site 8, splice variant 5, sequence conflict 5, sequence variant 4, transmembrane region 2, chain 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q53F39-F1 | 90.08 | 0.80 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (8): 303; 305; 77; 119; 119; 157; 249; 249
Mutagenesis-validated functional residues (9):
| Position | Phenotype |
|---|---|
| 77 | affects transport of gpi-anchor proteins. |
| 79 | affects transport of gpi-anchor proteins. |
| 119 | affects transport of gpi-anchor proteins. |
| 157 | affects transport of gpi-anchor proteins. |
| 158 | affects transport of gpi-anchor proteins. |
| 249 | affects transport of gpi-anchor proteins. |
| 303 | affects transport of gpi-anchor proteins. |
| 305 | affects transport of gpi-anchor proteins. |
| 392–394 | affects subcellular localization. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 189 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN, GOBP_PHOSPHOLIPID_METABOLIC_PROCESS, BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS, GOBP_GLYCOLIPID_BIOSYNTHETIC_PROCESS, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, MODULE_503, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS, GOBP_GLYCEROLIPID_METABOLIC_PROCESS, GOBP_PROTEIN_MATURATION, GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT, MODULE_195
GO Biological Process (3): GPI anchor biosynthetic process (GO:0006506), endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), vesicle-mediated transport (GO:0016192)
GO Molecular Function (6): manganese ion binding (GO:0030145), GPI-mannose ethanolamine phosphate phosphodiesterase activity (GO:0062050), protein binding (GO:0005515), phosphoric diester hydrolase activity (GO:0008081), hydrolase activity (GO:0016787), metal ion binding (GO:0046872)
GO Cellular Component (6): nucleoplasm (GO:0005654), Golgi apparatus (GO:0005794), endoplasmic reticulum-Golgi intermediate compartment membrane (GO:0033116), endoplasmic reticulum exit site (GO:0070971), endoplasmic reticulum-Golgi intermediate compartment (GO:0005793), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 3 |
| cellular anatomical structure | 3 |
| intracellular membrane-bounded organelle | 2 |
| GPI anchor metabolic process | 1 |
| glycolipid biosynthetic process | 1 |
| glycerophospholipid biosynthetic process | 1 |
| GPI anchored protein biosynthesis | 1 |
| intercellular transport | 1 |
| intracellular transport | 1 |
| Golgi vesicle transport | 1 |
| transport | 1 |
| cellular process | 1 |
| transition metal ion binding | 1 |
| phosphoric diester hydrolase activity | 1 |
| binding | 1 |
| phosphoric ester hydrolase activity | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
| nuclear lumen | 1 |
| endomembrane system | 1 |
| endoplasmic reticulum-Golgi intermediate compartment | 1 |
| bounding membrane of organelle | 1 |
| endoplasmic reticulum | 1 |
Protein interactions and networks
STRING
1280 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MPPE1 | CDC27 | P30260 | 963 |
| MPPE1 | BATF3 | Q9NR55 | 865 |
| MPPE1 | XCR1 | P46094 | 864 |
| MPPE1 | CLEC9A | Q6UXN8 | 852 |
| MPPE1 | GNAL | P38405 | 833 |
| MPPE1 | CD8A | P01732 | 782 |
| MPPE1 | ITGAE | P38570 | 722 |
| MPPE1 | THBD | P07204 | 717 |
| MPPE1 | XCL1 | P47992 | 713 |
| MPPE1 | IRF8 | Q02556 | 697 |
| MPPE1 | CD1C | P29017 | 697 |
| MPPE1 | ITGAX | P20702 | 697 |
| MPPE1 | SIRPA | P78324 | 690 |
| MPPE1 | ITGAM | P11215 | 653 |
| MPPE1 | ZBTB46 | Q86UZ6 | 644 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FLJ13057 | MPPE1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MPPE1 | ZNF426 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MPPE1 | FLJ13057 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MPPE1 | FAM234B | psi-mi:“MI:0914”(association) | 0.350 |
| SLC39A7 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC44A1 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC4A5 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (141): MPPE1 (Two-hybrid), ZNF426 (Two-hybrid), MUCL1 (Affinity Capture-MS), EDEM1 (Affinity Capture-MS), ICAM4 (Affinity Capture-MS), TMEM186 (Affinity Capture-MS), UGT3A2 (Affinity Capture-MS), GINM1 (Affinity Capture-MS), PIGB (Affinity Capture-MS), SEMA6A (Affinity Capture-MS), TMEM59L (Affinity Capture-MS), GALNT4 (Affinity Capture-MS), DHFRL1 (Affinity Capture-MS), FZD2 (Affinity Capture-MS), ALG12 (Affinity Capture-MS)
ESM2 similar proteins: A5D6U8, O23244, O48840, O97860, P06865, P07686, P08236, P09889, P13686, P20060, P29240, P29288, P29416, P49614, P80366, Q05117, Q0V8R6, Q38924, Q53F39, Q5MAU8, Q5R5N6, Q5RC84, Q5RET5, Q5RFI5, Q641X3, Q641Z7, Q687E1, Q6AYS4, Q6TPH1, Q6ZNF0, Q8BX37, Q8H1R2, Q8S340, Q8S341, Q8VYU7, Q8VYZ2, Q93WP4, Q949Y3, Q99KR8, Q9BTY2
Diamond homologs: B1WC86, C7G3A0, D2I2M6, Q0IHA5, Q53F39, Q566Y9, Q5RET5, Q5ZK82, Q80XL7, Q95X35, Q9GMS6, Q9VLR9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
67 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 51 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1706491 | GRCh37/hg19 18p11.22-11.21(chr18:9569601-12218695)x1 | Pathogenic |
| 1706501 | GRCh37/hg19 18p11.32-11.21(chr18:136226-14632436)x1 | Pathogenic |
SpliceAI
2830 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:11885829:G:T | acceptor_gain | 1.0000 |
| 18:11886912:CCTAC:C | donor_loss | 1.0000 |
| 18:11886913:CTACC:C | donor_loss | 1.0000 |
| 18:11886914:TACCT:T | donor_loss | 1.0000 |
| 18:11886916:C:CA | donor_loss | 1.0000 |
| 18:11886916:CCT:C | donor_gain | 1.0000 |
| 18:11887021:CAAAG:C | acceptor_gain | 1.0000 |
| 18:11887026:C:CC | acceptor_gain | 1.0000 |
| 18:11889380:TACTT:T | donor_loss | 1.0000 |
| 18:11889381:ACTTA:A | donor_loss | 1.0000 |
| 18:11889382:CT:C | donor_loss | 1.0000 |
| 18:11889383:TTA:T | donor_loss | 1.0000 |
| 18:11889384:TAC:T | donor_loss | 1.0000 |
| 18:11889385:A:AC | donor_gain | 1.0000 |
| 18:11889385:ACT:A | donor_gain | 1.0000 |
| 18:11889385:ACTCA:A | donor_loss | 1.0000 |
| 18:11889386:C:CA | donor_gain | 1.0000 |
| 18:11889386:CT:C | donor_gain | 1.0000 |
| 18:11889386:CTC:C | donor_gain | 1.0000 |
| 18:11889486:CAGGC:C | acceptor_gain | 1.0000 |
| 18:11889487:AGGCC:A | acceptor_loss | 1.0000 |
| 18:11889488:GGCCT:G | acceptor_loss | 1.0000 |
| 18:11889489:GCCTG:G | acceptor_loss | 1.0000 |
| 18:11889491:C:CC | acceptor_gain | 1.0000 |
| 18:11889491:CTGA:C | acceptor_loss | 1.0000 |
| 18:11889492:T:A | acceptor_loss | 1.0000 |
| 18:11893486:C:A | donor_gain | 1.0000 |
| 18:11893576:CCT:C | acceptor_gain | 1.0000 |
| 18:11893585:C:CT | acceptor_gain | 1.0000 |
| 18:11893586:A:T | acceptor_gain | 1.0000 |
AlphaMissense
2601 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 18:11885709:A:C | S325R | 0.998 |
| 18:11885709:A:T | S325R | 0.998 |
| 18:11885711:T:G | S325R | 0.998 |
| 18:11893502:T:A | D119V | 0.998 |
| 18:11887007:G:C | S196R | 0.997 |
| 18:11887007:G:T | S196R | 0.997 |
| 18:11887009:T:G | S196R | 0.997 |
| 18:11893502:T:G | D119A | 0.997 |
| 18:11893505:C:A | G118V | 0.997 |
| 18:11885724:G:C | S320R | 0.996 |
| 18:11885724:G:T | S320R | 0.996 |
| 18:11885726:T:G | S320R | 0.996 |
| 18:11885781:A:C | S301R | 0.996 |
| 18:11885781:A:T | S301R | 0.996 |
| 18:11885783:T:G | S301R | 0.996 |
| 18:11889408:T:G | H158P | 0.996 |
| 18:11889410:G:C | N157K | 0.996 |
| 18:11889410:G:T | N157K | 0.996 |
| 18:11893506:C:A | G118W | 0.996 |
| 18:11885708:A:G | W326R | 0.995 |
| 18:11885708:A:T | W326R | 0.995 |
| 18:11885716:G:A | S323F | 0.995 |
| 18:11889395:G:C | F162L | 0.995 |
| 18:11889395:G:T | F162L | 0.995 |
| 18:11889397:A:G | F162L | 0.995 |
| 18:11889409:G:C | H158D | 0.995 |
| 18:11893501:A:C | D119E | 0.995 |
| 18:11893501:A:T | D119E | 0.995 |
| 18:11893502:T:C | D119G | 0.995 |
| 18:11893503:C:G | D119H | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000089062 (18:11887927 G>A), RS1000339085 (18:11908365 G>A), RS1000367963 (18:11882415 C>T), RS1000534954 (18:11892521 T>G), RS1000580401 (18:11902934 C>T), RS1000580595 (18:11890339 C>T), RS1000642385 (18:11898489 T>C), RS1000694690 (18:11896539 A>G), RS1000776593 (18:11898269 G>A), RS1000970907 (18:11901497 C>T), RS1000992177 (18:11892138 G>A), RS1001198713 (18:11895458 C>A), RS1001251067 (18:11895243 A>G), RS1001422272 (18:11906623 G>A,C), RS1001499676 (18:11895842 G>T)
Disease associations
OMIM: gene MIM:611900 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | increases expression, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, increases expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Copper | increases expression, affects binding | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Disulfiram | affects binding, increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Lead | affects expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| tert-Butylhydroperoxide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.